A PET study with 18F-FDOPA and 11C-Raclopride on Parkinson's disease and related disorders patients.
Not Applicable
Recruiting
- Conditions
- Patients who are suspected Parkinson's disease or related disorders, including dementia with Lewy bodies, multiple system atrophy, progressive supranuclear palsy, corticobasal degeneration, frontotemporal lobe degeneration, vascular parkinsonism, drug-induced parkinsonism, normal pressure hydrocephalus, and others.
- Registration Number
- JPRN-UMIN000036952
- Lead Sponsor
- agoya City Rehabilitation Agency
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
Patients having history of seizure, alcoholism, or any kind of drug dependency. Patients recognized to be inappropriate by anyone of attending physicians or study staffs.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of conditions of dopamine metabolism and D2 receptor function among disorders.
- Secondary Outcome Measures
Name Time Method Relationship between clinical pictures and conditions of dopamine metabolism or D2 receptor function.